Growing community of inventors

Iabaraki, Japan

Hisakazu Kishimoto

Average Co-Inventor Count = 4.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Hisakazu Kishimoto ↔ Toshio Nishihara (2 patents)Hisakazu Kishimoto ↔ Yasuyuki Ueki (2 patents)Hisakazu Kishimoto ↔ Yumiko Kamikawa (2 patents)Hisakazu Kishimoto ↔ Ryu Nagata (1 patent)Hisakazu Kishimoto ↔ Nobuyuki Ae (1 patent)Hisakazu Kishimoto ↔ Yoshiharu Ikeda (1 patent)Hisakazu Kishimoto ↔ Yoshihara Ikeda (1 patent)Hisakazu Kishimoto ↔ Seiji Katayama (1 patent)Hisakazu KishimotoHisakazu Kishimoto (3 patents)Toshio NishiharaToshio Nishihara (13 patents)Yasuyuki UekiYasuyuki Ueki (6 patents)Yumiko KamikawaYumiko Kamikawa (4 patents)Ryu NagataRyu Nagata (13 patents)Nobuyuki AeNobuyuki Ae (3 patents)Yoshiharu IkedaYoshiharu Ikeda (2 patents)Yoshihara IkedaYoshihara Ikeda (1 patent)Seiji KatayamaSeiji Katayama (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sumitomo Pharmaceuticals Company Limited (3 from 174 patents)


3 patents:

1. 6495587 - Tricyclic indole-2-carboxylic acid compound used as NMDA receptor antagonist

2. 6048854 - 2,3-diaminopropionic acid derivative

3. 5707994 - 2,3-diaminopropionic acid derivative

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…